Combined Contraceptive – Other

Warning

Combined Contraceptive – Other

Total list (T)

EVRA PATCH®

  • Ethinylestradiol 33.9 micrograms/norelgestromin 203 microgram per 24 hours transdermal patch.
  • Restricted to use in patients who are unable to comply with oral contraceptives.

Specialist initiation (S1)

NUVARING®

  • Ethinylestradiol 2.7mg/Etonogestrel 11.7mg = 0.12mg/0.015mg per day vaginal delivery system.

NHSL Joint Adult Formulary Key

To indicate the category of a formulary medicine, updated sections adopt the following key:

Preferred list (P): First-line formulary choices.

Total list (T): Alternative choices when preferred list options not effective/not tolerated, or not indicated.

Specialist initiation (S1): Specialist initiation, or on the advice of a Consultant or Specialist Practitioner in this therapeutic area. Continuation in primary care is acceptable.

Specialist use only (S2): Supply via hospital, Homecare Service or a hospital based prescription (HBP) for dispensing by community pharmacy. Not prescribed in primary care setting.

Editorial Information

Last reviewed: 31/01/2022

Next review date: 31/01/2025

Author(s): NHSL.

Version: Please refer to the introduction section for an explanation of the review dates above.

Approved By: ADTC

Reviewer name(s): ADTC.